Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

If you are considering the GeneSight pharmacogenomic test to guide your mental health treatment, the decision is no longer just about the science; it is about navigating a complex 2026 landscape of ...

SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE)-- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its first ...

(MENAFN- GlobeNewsWire - Nasdaq) SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ: MYGN), a ...

Long gone are the days of picking up prints from your local film developer and then slipping them into family albums. Now, clicking around on a website (or swiping around on a phone app) for a few ...

The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...

Pharmacogenomic testing uses a DNA cheek swab to help predict how a patient's genes may influence their response to medications. Clinicians are using these tests to ...

This article was researched using 23 sources. See our methodology and corrections policy. Many people have heard that the list price of pharmacogenomic tests is high, yet typical out-of-pocket fees ...

In a hard year—and when, recently, have we had one we’d consider easy?—books can be a lifeline and a balm, a place to retreat and regain our grounding. Among the many entertaining, delightful, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." My daughter was in kindergarten when I first started testing books with kids. I invited her classmates to ...